Milestone Scientific to Present at The Noble Capital Markets Eighteenth Annual Investor Conference on April 21st
Milestone Scientific (NYSE:MLSS) announced that its President and CEO, Arjan Haverhals, will present at the Noble Capital Markets Eighteenth Annual Investor Conference on April 21, 2022, at 11:30 am ET in Seminole Ballroom D. Investors can meet management at breakout sessions on April 20. A video webcast of the presentation will be available the following day on the company’s website and other platforms for 90 days. Milestone specializes in advanced drug delivery systems, enhancing patient comfort and safety through innovative technologies.
- None.
- None.
ROSELAND, N.J., April 14, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that Arjan Haverhals, President and CEO of Milestone Scientific, will present at the Noble Capital Markets Eighteenth Annual Investor Conference being held on April 20-21, 2022 at the Hard Rock Hotel & Casino in Hollywood, Florida.
Mr. Haverhals will present on Thursday, April 21st at 11:30 am Eastern Time, in Seminole Ballroom D. Investors interested in meeting with management can meet at the breakout sessions on Wednesday, April 20th at 12:15 pm Eastern Time at Table 10 and at 3:15 pm Eastern Time at Table 6.
A high-definition, video webcast of the presentation will be available the following day on the Company's website https://www.milestonescientific.com/, and as part of a complete catalog of presentations available at Noble Capital Markets’ Conference website: www.nobleconference.com and on Channelchek www.channelchek.com the investor portal created by Noble. The webcast will be archived on the company's website, the NobleCon website and on Channelchek.com for 90 days following the event.
About Noble Capital Markets, Inc.
Noble Capital Markets (“Noble”) is a research driven investment bank that has supported small & microcap companies since 1984. As a FINRA and SEC licensed broker dealer Noble provides institutional-quality equity research, merchant and investment banking, and order execution services. In 2005, Noble established NobleCon, an investor conference that has grown substantially over the last decade. Noble launched www.channelchek.com in 2018 - an investor community dedicated exclusively to public small and micro-cap companies and their industries. Channelchek is the first service to offer institutional-quality research to the public, for FREE at every level without a subscription. More than 6,000 public emerging growth companies are listed on the site, with growing content including research, webcasts, podcasts, and balanced news.
About Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS), a technology focused medical research and development company that patents, designs and develops innovative injection technologies and instruments for medical, dental and cosmetic applications. Milestone Scientific’s computer-controlled systems are designed to make injections precise, efficient and increase the overall patient comfort and safety. Their proprietary DPS Dynamic Pressure Sensing Technology® instruments is the platform to advance the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions of subcutaneous drug delivery, including local anesthetic. To learn more, view the MLSS brand video or visit milestonescientific.com.
Safe Harbor Statement
This press release contains forward-looking statements regarding the timing and financial impact of Milestone's ability to implement its business plan, expected revenues, timing of regulatory approvals and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions, future business decisions and regulatory developments, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report for the year ended December 31, 2020. The forward-looking statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
Contact: David Waldman or Natalya Rudman
Crescendo Communications, LLC
Email: mlss@crescendo-ir.com
Tel: 212-671-1020
FAQ
When will Milestone Scientific present at the Noble Capital Markets Investor Conference?
Where can I watch Milestone Scientific's presentation?
What is the focus of Milestone Scientific's products?
How long will the webcast of the presentation be available?
Is there an opportunity to meet Milestone Scientific's management during the conference?
